Abstract
Carboplatin is currently recommended to be dosed according to renal function. In adults, dosing by the Calvert formula is based on evidence that carboplatin clearance closely parallels glomerular filtration rate. Several studies have attempted to validate the Calvert formula and its derivations in pediatrics, but no final consensus has been achieved. As a result, different versions of the original formula exist in the pediatric literature. Other factors may also contribute to confusion when applying the formula to young patients, including the manner in which renal function is measured and reported. We describe how misinterpretation of the Calvert formula resulted in carboplatin overdosing in 2 pediatric patients with high-risk neuroblastoma undergoing peripheral blood stem cell transplantation. Measures to avoid such errors have been instituted.
Original language | English (US) |
---|---|
Pages (from-to) | 818-821 |
Number of pages | 4 |
Journal | Journal of Pediatric Hematology/Oncology |
Volume | 25 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1 2003 |
Keywords
- Calvert
- Carboplatin
- Neuroblastoma
- Transplantation
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Oncology
- Hematology